Total Payments
$3,066
2024 Payments
$401.91
Companies
44
Transactions
171
Medicare Patients
5,012
Medicare Billing
$290,304
Payment Breakdown by Category
Food & Beverage$2,968 (96.8%)
Travel$87.56 (2.9%)
Education$10.52 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,968 | 169 | 96.8% |
| Travel and Lodging | $87.56 | 1 | 2.9% |
| Education | $10.52 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $654.35 | 38 | $0 (2024) |
| PFIZER INC. | $239.05 | 14 | $0 (2024) |
| Amgen Inc. | $211.41 | 6 | $0 (2024) |
| Novo Nordisk Inc | $162.88 | 10 | $0 (2024) |
| Organon LLC | $126.22 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $123.27 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $122.33 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $115.02 | 6 | $0 (2023) |
| Amarin Pharma Inc. | $106.98 | 7 | $0 (2022) |
| Lilly USA, LLC | $103.93 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $401.91 | 24 | ABBVIE INC. ($173.21) |
| 2023 | $590.03 | 32 | AbbVie Inc. ($207.79) |
| 2022 | $459.94 | 23 | ABBVIE INC. ($144.70) |
| 2021 | $309.99 | 18 | AbbVie Inc. ($101.49) |
| 2020 | $315.35 | 15 | Amgen Inc. ($91.71) |
| 2019 | $293.98 | 17 | PFIZER INC. ($138.05) |
| 2018 | $360.00 | 21 | Organogenesis Inc. ($87.56) |
| 2017 | $335.11 | 21 | Amgen Inc. ($66.25) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Endocrinology | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Obesity | ||||||
| 10/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Gastroenterology | ||||||
| 07/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Obesity | ||||||
| 07/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Bone Health | ||||||
| 05/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/07/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/29/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 02/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.32 | General |
| 01/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: VACCINE | ||||||
| 01/11/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Diabetes | ||||||
| 12/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,205 | 1,731 | $198,532 | $72,085 |
| 2022 | 21 | 1,318 | 1,782 | $192,808 | $63,718 |
| 2021 | 27 | 1,303 | 1,818 | $183,183 | $64,816 |
| 2020 | 18 | 1,186 | 1,659 | $172,364 | $89,685 |
Total Patients
5,012
Total Services
6,990
Medicare Billing
$290,304
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 274 | 658 | $103,964 | $27,947 | 26.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 66 | 66 | $19,800 | $18,666 | 94.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 175 | 175 | $29,750 | $7,574 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 146 | $15,476 | $5,542 | 35.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 175 | 175 | $4,463 | $3,017 | 67.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 63 | 63 | $1,701 | $1,667 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 55 | $1,485 | $1,455 | 98.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 53 | 55 | $1,375 | $1,124 | 81.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 29 | $826.50 | $1,073 | 129.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 110 | $2,200 | $1,047 | 47.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $3,824 | $692.78 | 18.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 13 | $4,368 | $670.55 | 15.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 19 | 19 | $874.00 | $595.40 | 68.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 36 | 36 | $4,374 | $395.45 | 9.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 39 | $1,404 | $352.14 | 25.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $414.00 | $119.90 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 33 | $2,079 | $76.96 | 3.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 26 | 31 | $155.00 | $68.20 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 291 | 655 | $103,490 | $29,793 | 28.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 171 | 171 | $29,070 | $8,261 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 169 | $17,914 | $7,047 | 39.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 172 | 172 | $4,386 | $3,049 | 69.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 78 | 78 | $2,106 | $2,065 | 98.1% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 79 | 79 | $1,975 | $1,585 | 80.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,527 | $1,564 | 61.9% |
About Dr. Eric Smith, M.D
Dr. Eric Smith, M.D is a Family Medicine healthcare provider based in Wooster, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972533214.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Smith, M.D has received a total of $3,066 in payments from pharmaceutical and medical device companies, with $401.91 received in 2024. These payments were reported across 171 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($2,968).
As a Medicare-enrolled provider, Smith has provided services to 5,012 Medicare beneficiaries, totaling 6,990 services with total Medicare billing of $290,304. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wooster, OH
- Active Since 07/03/2006
- Last Updated 05/02/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972533214
Products in Payments
- VRAYLAR (Drug) $270.38
- UBRELVY (Drug) $184.21
- Prolia (Biological) $171.10
- Vascepa (Drug) $106.98
- QULIPTA (Drug) $94.24
- VYNDAQEL (Drug) $93.20
- Affinity/NuShield/Puraply (Medical Supply) $87.56
- JARDIANCE (Drug) $79.93
- NEXPLANON (Drug) $77.26
- ENTRESTO (Drug) $76.46
- LINZESS (Drug) $75.15
- GVOKE HYPOPEN (Drug) $54.28
- ELIQUIS (Drug) $53.29
- Ozempic (Drug) $45.21
- Kerendia (Drug) $43.15
- NURTEC ODT (Drug) $41.84
- FARXIGA (Drug) $41.46
- EMGALITY (Drug) $40.36
- EVENITY (Biological) $40.31
- TRULICITY (Drug) $38.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wooster
Mr. Raymond Mason, Md, MD
Family Medicine — Payments: $7,837
Family Medicine $7,837
Dr. Paul Nielsen, Md, Ms, MD, MS
Family Medicine — Payments: $3,503
Family Medicine $3,503
John Miller, Md, MD
Family Medicine — Payments: $2,715
Family Medicine $2,715
Dr. Christopher Ranney, Md, MD
Family Medicine — Payments: $2,586
Family Medicine $2,586
Dr. Lisa Malys, Do, DO
Family Medicine — Payments: $1,420
Family Medicine $1,420
Kristin Wenger, D.o, D.O
Family Medicine — Payments: $1,383
Family Medicine $1,383